EUVIMEDEUVIMED entdecken
Open Access

Virologic Outcomes of Common First-Line Antiretroviral Regimens Among Adults with HIV — China, 2021–2023

Hanlu Jia, Yan Zhao, Yuan Guan, Jiang Liu, Yunxia Geng, Xiumin Gan, Yufen Liu

China CDC Weekly · 2026 · 8 (27) · 835-840

DOI: 10.46234/ccdcw2026.137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift China CDC Weekly, 2026. Verfasst von Hanlu Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Antiretroviral therapyHuman immunodeficiency virusViral suppression

Autor:innen und Institutionen

  • National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Office of General Administration, Chinese Center for Disease Control and Prevention & Chinese Academy of Preventive Medicine, Beijing, China.

Zitieren

APA

Jia, H., Zhao, Y., Guan, Y., Liu, J., Geng, Y., Gan, X., & Liu, Y. (2026). Virologic Outcomes of Common First-Line Antiretroviral Regimens Among Adults with HIV — China, 2021–2023. China CDC Weekly, 8(27), 835-840. https://doi.org/10.46234/ccdcw2026.137

Vancouver

Jia H, Zhao Y, Guan Y, Liu J, Geng Y, Gan X, et al. Virologic Outcomes of Common First-Line Antiretroviral Regimens Among Adults with HIV — China, 2021–2023. China CDC Weekly. 2026;8(27):835-840. doi:10.46234/ccdcw2026.137

BibTeX
@article{Jia2026,
  author = {Jia, Hanlu and Zhao, Yan and Guan, Yuan and Liu, Jiang and Geng, Yunxia and Gan, Xiumin and Liu, Yufen},
  title = {Virologic Outcomes of Common First-Line Antiretroviral Regimens Among Adults with HIV — China, 2021–2023},
  journal = {China CDC Weekly},
  year = {2026},
  volume = {8},
  number = {27},
  pages = {835--840},
  doi = {10.46234/ccdcw2026.137}
}
Kostenlos starten →